Accession Number: | 0001209191-20-011303 |
Date: | 2020-02-18 |
Issuer: | INTRA-CELLULAR THERAPIES, INC. (ITCI) |
Original Submission Date: |
SATLIN ANDREW
C/O INTRA-CELLULAR THERAPIES, INC.
430 EAST 29TH STREET
NEW YORK, NY 10016
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 23.94 | 2020-02-18 | deemed execution date | A | 26,754 (a) | 2030-02-17 | common stock 26,754 | $23.94 | 26,754 | direct | ||
RESTRICTED STOCK UNITS | 0.0 | 2020-02-18 | deemed execution date | A | 33,417 (a) | common stock 33,417 | $0.00 | 33,417 | direct |
ID | footnote |
---|---|
f1 | on february 18, 2020, the reporting person was granted options to purchase 26,754 shares of common stock, vesting in three equal annual installments beginning on the first anniversary of the grant date. |
f2 | each restricted stock unit represents a contingent right to receive one share of common stock. |
f3 | on february 18, 2020, the reporting person was granted 33,417 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. |